EGFR and neoplasm: The results of this study demonstrate that for a subset of patients presenting with EGFr cell membrane over-expression, resulting in reduced radiosensitivity with respect to a subset of patients with normal EGFr expression of clonogenic tumour cells, the dose per fraction should be increased to produce the same therapeutic effect with the same number of fractions taken in the reference treatment.